What are the treatment options for acne caused by Nexplanon (etonogestrel)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Nexplanon-Induced Acne

For acne caused by Nexplanon (etonogestrel implant), switch to a combined oral contraceptive containing drospirenone (ethinyl estradiol 30 mcg/drospirenone 3 mg) and initiate topical retinoid therapy with benzoyl peroxide. 1, 2

Understanding the Problem

Nexplanon is a progestin-only contraceptive that can trigger or worsen acne through androgenic stimulation of sebaceous glands, even at low doses. 3 This occurs because:

  • Progestin-only contraceptives lack the protective anti-androgenic effects of estrogen and may worsen acne 1
  • Etonogestrel implants have been documented to cause severe acne vulgaris within weeks to months after insertion 3
  • The androgenic activity stimulates sebaceous glands, leading to increased acne lesions 3

Primary Treatment Strategy: Switch Contraceptive Method

Remove the Nexplanon implant and transition to a combined oral contraceptive (COC) with proven anti-acne efficacy. 1, 3

First-Line COC Choice

  • Drospirenone-containing COC (ethinyl estradiol 30 mcg/drospirenone 3 mg) is the optimal choice for women with contraceptive-induced acne who still desire contraception 1
  • This formulation is FDA-approved specifically for acne treatment and provides superior anti-androgenic effects 1
  • Drospirenone minimizes the potential negative androgenic effects that other progestins may have on acne 4

Alternative COC Options

If drospirenone is contraindicated or not tolerated:

  • Norgestimate-containing COCs (ethinyl estradiol/norgestimate) 1
  • Norethindrone acetate-containing COCs (ethinyl estradiol/norethindrone acetate/ferrous fumarate) 1
  • All COCs have net anti-androgenic effects when combined with estrogen, regardless of progestin type 1

COC Contraindications to Screen For

Do not prescribe COCs if the patient has: 1

  • Current or history of deep vein thrombosis or pulmonary embolism
  • Current breast cancer or estrogen/progestin-sensitive cancers
  • Severe liver disease or hepatic tumors
  • Uncontrolled hypertension
  • Smoking if ≥35 years of age
  • Migraine with aura at any age, or migraine without aura if ≥35 years
  • Pregnancy

Concurrent Topical Acne Therapy

Initiate topical combination therapy immediately upon switching contraceptives to provide more rapid acne improvement. 1, 2

First-Line Topical Regimen

  • Topical retinoid (adapalene 0.1-0.3% or tretinoin 0.025-0.1%) PLUS benzoyl peroxide 2.5-5% applied once daily in the evening 2, 5
  • Start application every other day initially to minimize irritation, then advance to daily use as tolerated 5
  • Topical retinoids address comedone formation and inflammation while benzoyl peroxide reduces bacterial colonization 5

For Moderate-to-Severe Inflammatory Acne

If significant inflammatory lesions (papules, pustules, nodules) are present:

  • Add oral doxycycline 100 mg daily for 3-4 months maximum in combination with topical retinoid and benzoyl peroxide 2, 5
  • Always combine oral antibiotics with benzoyl peroxide to prevent bacterial resistance 2, 5
  • Never use antibiotics as monotherapy 2, 5

Alternative Hormonal Option: Spironolactone

If the patient cannot or prefers not to use COCs, spironolactone 50-100 mg daily is an effective alternative. 1

  • Spironolactone has potent anti-androgenic activity and can be used as monotherapy or adjunctive therapy 1
  • 66% of women achieve clear or markedly improved skin with spironolactone 1
  • Routine potassium monitoring is not required in young, healthy women without risk factors for hyperkalemia 1
  • Can be combined with COCs for severe cases: one study showed 85% of women with severe acne achieved clearance or excellent improvement using both spironolactone 100 mg daily and drospirenone-containing COC 6

Timeline for Improvement

Counsel patients that visible acne improvement requires 3-6 months of hormonal therapy. 1

  • Statistically significant improvement becomes evident by cycle 3 (approximately 3 months) with COCs 1
  • Early combination with topical medications provides more immediate benefit during this initial period 1
  • Common COC side effects (breakthrough bleeding, nausea, breast tenderness) typically resolve within 2-3 cycles, often before acne improvement becomes apparent 1

Monitoring and Follow-Up

  • Measure blood pressure before initiating COCs 1
  • Follow-up at 3 months to assess initial response and side effects 1
  • Follow-up at 6 months to assess maximal benefit 1
  • If using spironolactone, consider baseline potassium level and repeat at 4-6 weeks only if risk factors for hyperkalemia exist 1, 6

Critical Pitfalls to Avoid

  • Never continue progestin-only contraceptives (like Nexplanon) in patients with worsening acne 1
  • Do not use topical or oral antibiotics as monotherapy—always combine with benzoyl peroxide 2, 5
  • Do not extend oral antibiotics beyond 3-4 months without re-evaluation 2
  • Do not withhold COCs from appropriate candidates due to misconceptions about antibiotic interactions 1

Maintenance After Clearance

  • Continue topical retinoid therapy indefinitely after achieving clearance to prevent recurrence 2
  • Benzoyl peroxide can be continued as maintenance therapy 2
  • Continue hormonal therapy (COC or spironolactone) as long as contraception is desired or hormonal acne control is needed 1

References

Guideline

Best Birth Control for Acne

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Acne Vulgaris Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Worsening Acne

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.